Editas Medicine Excess Tax Benefit from Stock Compensation (Quarterly) Trends

Editas Medicine, Inc. (EDIT)

2.02 -0.01 (-0.49%) USD | NASDAQ | Jan 20, 16:00

2.025 0.00 (0.00%) After-Hours: 20:00

View Excess Tax Benefit from Stock Compensation (Quarterly) for EDIT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Excess Tax Benefit from Stock Compensation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks

Start Trial

ADMA Biologics, Inc.	--
Arcutis Biotherapeutics, Inc.	--
Daré Bioscience, Inc.	--
Cogent Biosciences, Inc.	--
Janux Therapeutics, Inc.	--